Clinical Trial

De-identified Human Tissue Project

Recruiting
View on ClinicalTrials.gov →
Summary
Research scientists of the University of Central Florida College of Medicine (COM) and Burnett School of Biomedical Sciences (BSBS) conduct laboratory studies in biomedical and translational medical research for the purpose of understanding human disease and developing innovative methods for diagnosing, measuring, or treating disease or disease symptoms. The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-10-08; most recent amendment 2024-12-03.
Trial Details
NCT Number NCT06082687
Lead Sponsor University of Central Florida
Conditions Tissue
Enrollment 1,000,000 participants
Start Date 2022-09-14
Primary Completion 2027-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2024-12-06